Q3 Adjusted EPS Beats at $2.08, But Sales Miss at $561.7M
DORM sits 27% above its 52-week low of $98.445.
Summary
Dorman posted Q3 adjusted EPS of $2.08 against an IBES estimate of $2.00, a modest beat, while sales of $561.7M came in just below the $563.4M consensus. GAAP EPS was $1.98. The top-line shortfall is the wrinkle: Q2 had been powered by $98.1M in IEEPA tariff refunds and the company raised full-year guidance to $7.93–$8.23 at that time, so the question now is whether that outlook still holds. The company now sees 2026 EPS of $7.95–$8.15 and 2026 adjusted EPS of $8.50–$8.70, and expects full-year net sales growth in the range of 2% to 3%.
At the time of this announcement, DORM was trading at $124.74 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $3.7B. The 52-week trading range was $98.45 to $164.00. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.